These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8757005

  • 21. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents.
    Winner P, Rothner AD, Saper J, Nett R, Asgharnejad M, Laurenza A, Austin R, Peykamian M.
    Pediatrics; 2000 Nov; 106(5):989-97. PubMed ID: 11061765
    [Abstract] [Full Text] [Related]

  • 22. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172
    [Abstract] [Full Text] [Related]

  • 23. A Phase 1, Randomized, Open-Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects.
    Albrecht D, Iwashima M, Dillon D, Harris S, Levy J.
    Headache; 2020 Apr; 60(4):701-712. PubMed ID: 31985049
    [Abstract] [Full Text] [Related]

  • 24. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine.
    Peikert A, Becker WJ, Ashford EA, Dahlof C, Hassani H, Salonen RJ.
    Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349
    [Abstract] [Full Text] [Related]

  • 25. [Migraine: dihydroergotamine nasal spray--an alternative].
    Beubler E.
    Wien Med Wochenschr; 1995 Jan; 145(14):326-31. PubMed ID: 7483646
    [Abstract] [Full Text] [Related]

  • 26. How does sumatriptan nasal spray perform in clinical practice?
    Dahlöf CG, Boes-Hansen S, Cederberg CG, Hardebo JE, Henriksson A.
    Cephalalgia; 1998 Jun; 18(5):278-82. PubMed ID: 9673808
    [Abstract] [Full Text] [Related]

  • 27. Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group.
    Gallagher RM.
    Arch Neurol; 1996 Dec; 53(12):1285-91. PubMed ID: 8970458
    [Abstract] [Full Text] [Related]

  • 28. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M, Marbury T, O'Neill C, Siegel S, Du W, Sebree T.
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [Abstract] [Full Text] [Related]

  • 29. Sumatriptan. An updated review of its use in migraine.
    Perry CM, Markham A.
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [Abstract] [Full Text] [Related]

  • 30. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G, Valette C.
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC.
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [Abstract] [Full Text] [Related]

  • 32. Parental satisfaction with sumatriptan nasal spray in childhood migraine.
    Pakalnis A, Kring D, Paolicchi J.
    J Child Neurol; 2003 Nov; 18(11):772-5. PubMed ID: 14696905
    [Abstract] [Full Text] [Related]

  • 33. Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group.
    Boureau F, Chazot G, Emile J, Bertin L, d'Allens H.
    Eur Neurol; 1995 Nov; 35(5):264-9. PubMed ID: 8542914
    [Abstract] [Full Text] [Related]

  • 34. Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo.
    Tulunay FC, Karan O, Aydin N, Culcuoglu A, Guvener A.
    Cephalalgia; 1987 Jun; 7(2):131-3. PubMed ID: 3301001
    [Abstract] [Full Text] [Related]

  • 35. One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study.
    Rothner AD, Winner P, Nett R, Asgharnejad M, Laurenza A, Austin R, Peykamian M.
    Clin Ther; 2000 Dec; 22(12):1533-46. PubMed ID: 11192144
    [Abstract] [Full Text] [Related]

  • 36. Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group.
    Gross ML, Kay J, Turner AM, Hallett K, Cleal AL, Hassani H.
    Headache; 1994 Dec; 34(10):559-63. PubMed ID: 7843948
    [Abstract] [Full Text] [Related]

  • 37. Treatment of acute cluster headache with 20 mg sumatriptan nasal spray--an open pilot study.
    Schuh-Hofer S, Reuter U, Kinze S, Einhäupl KM, Arnold G.
    J Neurol; 2002 Jan; 249(1):94-9. PubMed ID: 11954875
    [Abstract] [Full Text] [Related]

  • 38. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
    Carleton SC, Shesser RF, Pietrzak MP, Chudnofsky CR, Starkman S, Morris DL, Johnson G, Rhee KJ, Barton CW, Chelly JE, Rosenberg J, Van Valen MK.
    Ann Emerg Med; 1998 Aug; 32(2):129-38. PubMed ID: 9701293
    [Abstract] [Full Text] [Related]

  • 39. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations.
    Weidmann E, Unger J, Blair S, Friesen C, Hart C, Cady R.
    Clin Ther; 2003 Jan; 25(1):235-46. PubMed ID: 12637123
    [Abstract] [Full Text] [Related]

  • 40. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.